Compare GILT & SMTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GILT | SMTI |
|---|---|---|
| Founded | 1987 | 1982 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | Radio And Television Broadcasting And Communications Equipment | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 877.0M | 313.5M |
| IPO Year | 1997 | 2008 |
| Metric | GILT | SMTI |
|---|---|---|
| Price | $11.14 | $34.32 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 2 |
| Target Price | $19.00 | ★ $34.00 |
| AVG Volume (30 Days) | ★ 556.2K | 313.8K |
| Earning Date | 05-13-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.05 |
| Revenue | N/A | ★ $15,586,976.00 |
| Revenue This Year | $15.06 | $17.31 |
| Revenue Next Year | $11.72 | $12.48 |
| P/E Ratio | ★ $42.82 | $685.00 |
| Revenue Growth | N/A | ★ 32.47 |
| 52 Week Low | $8.52 | $16.05 |
| 52 Week High | $20.99 | $35.70 |
| Indicator | GILT | SMTI |
|---|---|---|
| Relative Strength Index (RSI) | 41.79 | 82.95 |
| Support Level | $10.26 | $20.47 |
| Resistance Level | $13.82 | $34.33 |
| Average True Range (ATR) | 0.59 | 0.85 |
| MACD | 0.11 | 0.37 |
| Stochastic Oscillator | 39.91 | 99.05 |
Gilat Satellite Networks Ltd is a provider of satellite-based broadband communications. The company designs and manufactures ground-based satellite communications equipment and provides comprehensive solutions and end-to-end services. Its portfolio includes a cloud-based satellite network platform, very small aperture terminals (VSATs), amplifiers, high-speed modems, on-the-move antennas and high-power solid-state power amplifiers (SSPAs), block-up converters (BUCs), and Transceivers. The company operates in three operating segments: Gilat Commercial Division, Gilat Defense Division, and Gilat Peru Division. The majority of its revenue is generated from the Gilat Commercial segment.
Sanara MedTech Inc is a medical technology company focused on developing and commercializing technologies to improve clinical outcomes and reduce healthcare expenditures in the surgical market. It markets and sells soft tissue repair and bone fusion products for use in operating rooms and sterile environments. Its soft tissue repair products include CellerateRX Surgical Powder, a hydrolyzed collagen used in management of surgical wounds, and BIASURGE Surgical Solution, a sterile no-rinse solution for wound irrigation, while its bone fusion products include BiFORM Bioactive Moldable Matrix, an osteoconductive implant that supports bone growth, and ALLOCYTE Plus Viable Bone Matrix, a human allograft cellular bone matrix containing bone-derived progenitor cells and conformable bone fibers.